Quadro severo di mieloma multiplo e insufficienza renale trattato con successo con bortezomib e desametasone

Abstract

Italian

Keywords

Mieloma Bortezomib Terapia Proteinuria di Bence Jones

Get full access to this article

View all access options for this article.

References

Arai

, Matsuzaki

. Renal failure. Nippon Rinsho 1995; 53(3): 703–9.

Dimopoulos

M.A.

, Kastritis

, Rosinol

, Biadè

, Ludwing

. Pathogenesis and treatment of renal failure in multiple myeloma. Leukemia 2008; 22(8): 1485–93. Epub 2008 Jun 5.

Basic-Jukic

, Kes

, Labar

. Myeloma kidney: pathogenesis and treatment. Acta Med Croatica 2001; 55(4-5): 169–75.

Boccadoro

, Cavo

, Palumbo

Bortezomib nel mieloma multiplo. Edizione speciale 2010.

Il Pensiero Scientifico Editore 2010; 56–60.

Ludwig

, Adam

, Hajek

. Bortezomib-doxorubicin-dexamethasone (BDD) in patients with acute light chain induced renal failure (ARF) in multiple myeloma (MM). Final results of a phase II study. Blood 2009; 114: Abs 3862.

Roussou

, Kastritis

, Christoulas

. Reversibility of renal failure in newly diagnosed patients with multiple myeloma and the role of novel agents. Blood 2009; 114: Abs 955.